Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles (2017)
Attributed to:
Protection of neurons in vitro and in vivo from Synuclein toxicity by molecular tweezers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0181844
PubMed Identifier: 28797124
Publication URI: http://europepmc.org/abstract/MED/28797124
Type: Journal Article/Review
Parent Publication: PLOS ONE
Issue: 8
ISSN: 1932-6203